Who are Theragen's investors?

Theragen's investors include K2 HealthVentures.

How much funding has Theragen raised?

Theragen has disclosed $10.4M raised across 3 rounds.

Where is Theragen headquartered?

Theragen is headquartered in Manassas, US.

Theragen

Manassas, US · Founded 2014 · 167 employees on LinkedIn · 1 known investors

Find your way into Theragen

ActaStim offers an FDA-approved electrical bone growth stimulation device used as an adjunct to lumbar spinal fusion surgery to improve fusion success and reduce failure rates. It is a medical device in the orthopedic/spine care category.

Healthtech Medical Devices

Founders & leadership

Jon Christopher McAuliffeExecutive

Gary GrenterinPresident, CEO & Co-Founder2014–2017Gary Grenter is an executive with 35 years of experience in sales, marketing, engineering, and operations across medical device companies including Stryker Orthopedics, Kyphon Inc. (which he led to IPO in 2002), Biolectron, SpineAlign Medical, and Spacelabs Healthcare. He holds a B.S. in Production Management from Northern Illinois University and an M.B.A. in Management from the Rochester Institute of Technology.

Board

Jan A. BuckBoard director

Kimball ChenBoard director

Alex W. EvansBoard director

Frithjof FuchsBoard director

Investors · 1

K2 HealthVenturesBoston · $10M – $100M

Reported raises · per SEC filings

Form D private placements

$10.4M disclosed across 3 rounds · 2016–2017

▶$1.3MraisedJun 2017 · 2 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Kimball ChenDirector
Jon Christopher McAuliffeExecutive Officer
Matthew RiceDirector
Gary GrenterExecutive Officer, Director
Alex W. EvansDirector

Offering amount: $2.3M
Amount sold: $1.3M
First sale: Jun 2017
Incorporated: Corporation, Delaware, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$1.3MraisedFeb 2017 · 2 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Alex W. EvansDirector
Matthew RiceDirector
Gary GrenterExecutive Officer, Director
Kimball ChenDirector
Jon Christopher McAuliffeExecutive Officer

Offering amount: $2.5M
Amount sold: $1.3M
First sale: Feb 2017
Incorporated: Corporation, Delaware, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$7.9MraisedAug 2016 · 6 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Jon Christopher McAuliffeExecutive Officer
Jan A. BuckDirector
Kimball ChenDirector
Alex W. EvansDirector
Gary GrenterExecutive Officer, Director
Frithjof FuchsDirector

Offering amount: $9.9M
Amount sold: $7.9M
Finders' fees: $423.6K
Placement agents: Source Capital Group, Inc.
First sale: Aug 2016
Incorporated: Corporation, Delaware, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Orthofix (NASDAQ:OFIX)33 shared keywordsOrthofix develops medical devices and surgical solutions for orthopedic procedures, with a focus on spine surgery and limb reconstruction. The company serves physicians and patients globally and emphasizes product quality, safety, and environmental responsibility in its operations.

Companies competing with Theragen for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Theragen do?: ActaStim offers an FDA-approved electrical bone growth stimulation device used as an adjunct to lumbar spinal fusion surgery to improve fusion success and reduce failure rates. It is a medical device in the orthopedic/spine care category.
Who are Theragen's investors?: Theragen's investors include K2 HealthVentures.
How much funding has Theragen raised?: Theragen has disclosed $10.4M raised across 3 rounds.
Where is Theragen headquartered?: Theragen is headquartered in Manassas, US.